» Articles » PMID: 36903263

Molecular Docking and In Vitro Studies of Ochratoxin A (OTA) Biodetoxification Testing Three Endopeptidases

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Mar 11
PMID 36903263
Authors
Affiliations
Soon will be listed here.
Abstract

Ochratoxin A (OTA) is considered one of the main mycotoxins responsible for health problems and considerable economic losses in the feed industry. The aim was to study OTA's detoxifying potential of commercial protease enzymes: (i) bromelain cysteine-protease, (ii) bovine trypsin serine-protease and (iii) neutral metalloendopeptidase. In silico studies were performed with reference ligands and T-2 toxin as control, and in vitro experiments. In silico study results showed that tested toxins interacted near the catalytic triad, similar to how the reference ligands behave in all tested proteases. Likewise, based on the proximity of the amino acids in the most stable poses, the chemical reaction mechanisms for the transformation of OTA were proposed. In vitro experiments showed that while bromelain reduced OTA's concentration in 7.64% at pH 4.6; trypsin at 10.69% and the neutral metalloendopeptidase in 8.2%, 14.44%, 45.26% at pH 4.6, 5 and 7, respectively ( < 0.05). The less harmful α-ochratoxin was confirmed with trypsin and the metalloendopeptidase. This study is the first attempt to demonstrate that: (i) bromelain and trypsin can hydrolyse OTA in acidic pH conditions with low efficiency and (ii) the metalloendopeptidase was an effective OTA bio-detoxifier. This study confirmed α-ochratoxin as a final product of the enzymatic reactions in real-time practical information on OTA degradation rate, since in vitro experiments simulated the time that food spends in poultry intestines, as well as their natural pH and temperature conditions.

Citing Articles

Suppression of mycotoxins production and efficient chelation of heavy metals using natural melanin originated from Aspergillus flavus and Aspergillus carbonarius.

El-Gazzar N, Abdo E, Rabie G, El-Sayed M BMC Biotechnol. 2025; 25(1):6.

PMID: 39794745 PMC: 11724575. DOI: 10.1186/s12896-024-00941-7.


Study of as an Effective Multi-Type A Trichothecene Inactivator.

Garcia-Garcia F, Cristiani-Urbina E, Morales-Barrera L, Rodriguez-Pena O, Hernandez-Portilla L, Campos J Microorganisms. 2024; 12(11).

PMID: 39597625 PMC: 11596695. DOI: 10.3390/microorganisms12112236.


Mycotoxin Biodegradation by Bacteria-A Review.

Nguyen T, Chen X, Ma L, Feng Y Toxins (Basel). 2024; 16(11).

PMID: 39591233 PMC: 11598562. DOI: 10.3390/toxins16110478.


Bioprospecting of sp. as a promising repository for anti-cancer agents: a comprehensive bibliometric investigation.

Jangid H, Garg S, Kashyap P, Karnwal A, Shidiki A, Kumar G Front Microbiol. 2024; 15:1379602.

PMID: 38812679 PMC: 11133633. DOI: 10.3389/fmicb.2024.1379602.


Comprehensive Insights into Ochratoxin A: Occurrence, Analysis, and Control Strategies.

Ben Miri Y, Benabdallah A, Chentir I, Djenane D, Luvisi A, De Bellis L Foods. 2024; 13(8).

PMID: 38672856 PMC: 11049263. DOI: 10.3390/foods13081184.


References
1.
Muller G, Burkert B, Moller U, Diller R, Rohrmann B, Rosner H . Ochratoxin A and some of its derivatives modulate radical formation of porcine blood monocytes and granulocytes. Toxicology. 2004; 199(2-3):251-9. DOI: 10.1016/j.tox.2004.01.040. View

2.
Vernet T, Tessier D, CHATELLIER J, Plouffe C, Lee T, Thomas D . Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem. 1995; 270(28):16645-52. DOI: 10.1074/jbc.270.28.16645. View

3.
Solfrizzo M, Avantaggiato G, Visconti A . Use of various clean-up procedures for the analysis of ochratoxin A in cereals. J Chromatogr A. 1998; 815(1):67-73. DOI: 10.1016/s0021-9673(98)00271-4. View

4.
Azam M, Yu D, Liu N, Wu A . Degrading Ochratoxin A and Zearalenone Mycotoxins Using a Multifunctional Recombinant Enzyme. Toxins (Basel). 2019; 11(5). PMC: 6563298. DOI: 10.3390/toxins11050301. View

5.
Zheng Y, Chen Q, Shan A, Zhang H . Optimisation of the enzymatic hydrolysis of blood cells with a neutral protease. Biomed Res Int. 2013; 2013:278927. PMC: 3591104. DOI: 10.1155/2013/278927. View